Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era
Author:
Publisher
Elsevier BV
Subject
Urology
Reference28 articles.
1. Cancer Statistics, 2000;Greenlee;Ca Cancer J Clin,2000
2. Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era;Gilliland;Urology,1996
3. Immediate versus deferred treatment for advanced prostatic cancer;Br J Urol,1997
4. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer;Messing;N Engl J Med,1999
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and validation of a novel risk model in newly diagnosed de novo bone metastatic prostate cancer (M1b): a retrospective study;PeerJ;2023-01-12
2. Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones;Nature Communications;2022-09-17
3. Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study;BMC Urology;2022-09-14
4. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: A systematic review and meta-analysis;PLOS ONE;2021-06-08
5. Treatment and trials in non-metastatic castration-resistant prostate cancer;Nature Reviews Urology;2021-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3